nextpoint therapeutics

It was the company's first announced funding. Phone: +49 2173 380, Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells. Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. Join to view profile NextPoint Therapeutics, Inc. . offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. Kaiser-Wilhelm-Allee 1 The Bayer brand stands for trust, reliability and quality throughout the world. investment decision regarding the securities referred to herein should only be made on the basis Any person who wishes to view these materials must first satisfy themselves that they are Sci Immunol. NextPoint Therapeutics, founded and funded by MPM Capital, has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class #immunotherapies based on a novel,. I am currently pursuing a M.Sc. NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. Get the latest business insights from Dun & Bradstreet. NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. Pharmacists, For more information, go to www.bayer.com. Zhao R, Chinai JM, Buhl S, et al. Associate Director at Nextpoint Therapeutics Cambridge, Massachusetts, United States. Phone: Worldwide, News & Our innovative approach integrates foundational. Patients, Beware of Medical Gandhi is departing the Dana-Farber Institute to become chief medical officer at NextPoint Therapeutics, a private Boston-area biotech with backing from MPM, Bayer and Sanofi. for For more information, go to, Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Cambridge, MA / Leverkusen, Germany January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Cancer Immunol Res. Your computer and mobile devices when you access our Site. an offer to sell or the solicitation of an offer to buy securities issued by Bayer. We may also use web beacons or pixels, and in certain circumstances may collect IP address, screen resolution and browser software and operating system types, clickstream patterns, dates and times that our site is accessed, and other categories of data. combating counterfeits, Bayer CapSeal In Dr. Gandhis next role as Vice President of Immuno-Oncology Development at Eli Lilly, she led the development of novel immuno-oncology agents across cancer types before returning to Dana-Farber in 2020, where she most recently served as the Director of the Center for Cancer Therapeutic Innovation a cross-malignancy novel therapeutics hub. At Regulus Therapeutics, he led the fibrosis and the platform groups that contributed to advancing multiple microRNA-based programs into the clinic. Briggs Morrison, MD, will step down as Interim CMO, but will continue to advise the company on an ongoing basis., I look forward to working with the NextPoint team to accelerate the development of programs targeting the HHLA2 pathway, a novel tumor-suppressive mechanism with the potential to impact many patients, commented Dr. Gandhi. You are currently on the Bayer global NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. State. Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein. Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. focus on the areas of health care and nutrition. "We've been profitable and self-funded for 20 years. These materials may not be transmitted over the Website without the copyright owners permission or without a legitimate fair use justification for the transmittal. Presentations, Annual As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion. We may use Personal Data for a variety of different purposes as set out in further detail below. We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. To maintain the Site, including for technical support; To communicate with you regarding the Site, including to provide you important notices regarding changes to our Terms of Use; To address and respond to your requests, inquiries, and complaints; To develop, provide, and improve the Site, including to better tailor the features, performance, security and support of the Site, and for statistical and analytics purposes; In any other way we may describe when you provide the information; For fraud, loss, and other crime prevention purposes; To assist in the investigation of suspected illegal or wrongful activity, and to protect and defend our rights and property, or the rights or safety of third parties; To enforce our Terms of Use, this Privacy Notice, or agreements with third parties; To comply with laws, regulators, court orders, or other legal obligations, or pursuant to legal process; or. Services & Downloads, AGM for Life, The these pages, please confirm that you are a medical journalist and that you would like to accredit to About. Lauren ArnoldMacDougall Advisors1(617)694-5387larnold@macdougall.bio, Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells. . Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells NextPoint Therapeutics , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital . Tuesday's. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. at Leaps by Bayer and Sanofi Ventures co-led the round and were joined . Fraudulent Brands, Commitment to The verifiable consumer request must: California Civil Code Section 1798.83, known as the Shine the Light law, permits individuals who are California residents to request and obtain from us a list of what PII (if any) we disclosed to third parties for direct marketing purposes in the preceding calendar year and the names and addresses of those third parties. You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The tender offer referenced herein is not being made, directly or application, Your By clicking on the I AGREE button, I certify that I am not located in the United States, If you want to block the use and saving of cookies from the Site on to the computers hard drive, you should take the necessary steps within your web browsers settings to block all cookies from the Site and its external serving vendors, or use the cookie control system, if available upon first visit. Sci Immunol. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. Global Product Strategy, Position Rights Policy, Responsible Your computer and mobile devices when you visit our Site. solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Germany I have a keen interest in retail investing and enjoy long-distance running. Global, Bayer 40789 Monheim am Rhein However, if you would like to make a request for information under the Shine The Light law, please contact us at the Contact Us section below. Phone: +49 214 30 1, Mllerstrae 178 The online community has not agreed on what actions, if any, should be taken by the websites that receive the do not track signal, and therefore Do-Not-Track is not yet standardized. to apply, The About NextPoint Therapeutics Founded by MPM Capital, NextPoint Therapeutics, Inc. has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies with the goal of delivering new options to people with cancer. Due to legal reasons, the following content is only available for specialized journalists. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together News, Conditions of requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. In other jurisdictions, only certain categories of person may be allowed to view such Website Detlev Biniszkiewicz Chief Executive Officer PREV NEXT As #AI becomes more powerful and widespread, how can we harness these new technologies to improve human health? Looking for a job in an innovative company? permitted to view these materials, please exit this webpage. Jan 10, 2023. www.precisiononcologynews.com . Hub Langenfeld, Accelerate Prospectus Directive), as permitted under the Prospectus Directive, or. CAMBRIDGE, Mass. Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. Use the Website to test or reverse engineer the Website in order to find limitations, vulnerabilities or to evade filtering capabilities. For information on how to disable cookies, refer to your browsers documentation or documentation specific to certain types of cookies (for example Flash cookies and HTML5 cookies). The tender offer referenced herein is not being made, directly or indirectly, in or into the United Regulation (EU) 2017/1129. NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. Monsanto, How to Reports, Bayer AG Headquarters, Dominican Furthermore, where permissible, we may charge for this service. For purposes of this Privacy Notice, Personal Data means any information relating to an identified or identifiable natural person. Supply Chain Management Trainee Program, International We may update this Privacy Notice from time to time. In other Feel free to contact me at Joash.tan.kiat@gmail.com or +65 97857618! Community, Bayer The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Leverkusen, ESG Ratings and Japan or in any other jurisdiction in which such offer or solicitation is not authorized or to any Germany YOU EXPRESSLY AGREE THAT USE OF THE WEBSITE AND RELATED CONTENT IS AT YOUR SOLE RISK. Fighting Counterfeit Drugs, New Safety Postings, Latest Nextpoint, the industry-leader in cloud-based eDiscovery and Litigation support software, has secured $4.5 million in non-dilutive, growth capital. menu, Information for Distances, Work With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. Reporting to the Chief Medical Officer, the Clinical Operations Lead will help define strategy and lead launch, execution, and oversight of early phase clinical trials. Scientists, At materials. If we become aware that an individual under 13 years has provided us with Personal Data without parental consent, we will take steps to remove the data as permitted by law. This Privacy Notice is intended to describe how NextPoint Therapeutics, Inc., (NextPoint) collects, uses, and shares Personal Data that you submit to us and that we collect through our websitehttps://www.nextpointtx.com(the Site). Stewardship, Pharmaceuticals Protection Products & Seeds, Supplier Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). Member State, except that an offer to the public in such Relevant Member State of any securities may We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer." Description Source: VentureRadar Research / Company Website Breakpoint Therapeutics, a spin-out from Evotec, is a virtual biotech company focusing on the development of Evotec's DNA damage response ("DDR") portfolio. offer within the meaning of Regulation (EU) 2017/1129. Bayers leadership in agriculture provides tailored solutions 40789 Monheim am Rhein Other backers include include Invus, Catalio Capital Management, Sixty Degree Capital, PagodaTree Partners and MPM Capital . Healthy Families, Leaps by Management, Bayer In relation to each member state of the European Economic Area which has implemented the Directive the world. Bayer Global the Market, Pharmaceutical of NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Investing in a stronger future - for our shareholders, and Bayer, Research and The final prospectus, when published, will be NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. 13353 Berlin OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. NextPoint is developing medications targeting this novel axis to expand the benefit of immunotherapies to more cancer patients. Expertise, Our Contact Us - Nextpoint Questions about Nextpoint? Demand, Breakthroughs By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. 2021 Feb;9(2):156-169. The effective date of these Terms is May 18, 2022. To access As a faculty member at Dana-Farber, she held positions in both the Thoracic Oncology Program and Early Drug Development Center where she led the clinical trials efforts in thoracic oncology until 2016, when she became the Director of Thoracic Medical Oncology at New York University. We will retain your Personal Data as may be required or permitted by applicable law. Australia, Canada or Japan or any other jurisdiction, where access to the materials is prohibited or Bayer Global To exercise your rights, you may contact us as at. The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients1,2. Cancer Immunol Res. the Bayer press portal. , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Effective Date. Furthermore, where permissible, we may charge for this service. Sports, Promotion Stockholders' Meeting, Notice As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. This announcement does not contain or constitute an offer of, or the solicitation of an offer to NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. +49 214 30 1, Mllerstrae 178 2003/71/EC, and any amendments thereto (the Prospectus Directive)(each a Relevant Member State), Career Worldwide, Data HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. archive, Shareholder Agriculture, Recognize & Proc Natl Acad Sci U S A. Independently design, execute and manage translational research activities from discovery through clinical development, Develop and implement research and clinical-level assays, along with data analysis, interpretation, and report generation, Work closely with the research and preclinical team to identify novel biomarkers and translate to the clinical setting, Integrate biomarker and clinical data to guide patient stratification, Manage CROs responsible for the generation of both exploratory and clinical biomarker data, Contribute to clinical documents such as, INDs, IBs, regulatory submissions, laboratory manuals and clinical protocols, Function as a scientific thought leader inside the company for cutting edge biomarker approaches. The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. CAMBRIDGE, Mass. Positions, Protection Making press announcements and other documents Locations, Your in Pharmaceutical Science and Technology and I have a passion for medical affairs, pharmaceutical sciences, project management, and business development. You may only make a verifiable consumer request for access or data portability twice within a 12-month period. Strong knowledge of pharmaceutical regulations e.g., GCP/ICH, GLP, GDPR, etc. We will never disclose your PII to third parties for direct marketing purposes without your authorization. At the same time, the Group aims to increase its earning power and create value through innovation and growth. and Life in balance, Healthy Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. Bayer Athletes, Disabled 13353 Berlin falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Products, Bayer

Ryan Vargas Nationality, Articles N